London, UK, 10 September 2019 – Instinctif Partners, the international business communications consultancy, congratulates all nominees shortlisted as finalists for the Lifestars Awards 2019. The annual Lifestars Awards brings together European leaders, investors, partners and deal makers across the industry to celebrate achievements that have been made throughout Europe over the last 12 months.
Particular congratulations goes to the 12 clients of Instinctif Partners Life Sciences’ practice who have been selected as finalists across 10 of the 16 highly coveted award categories. These are:
Series A Raise of the Year
• Confo Therapeutics
IPO of the Year
• HOOKIPA Pharma
Venture Capital Firm of the Year
• Seventure Partners
Deal of the Year (<£500m)
• Confo Therapeutics and Dynabind
• Crescendo Biologics and Takeda
Deal of the Year (>£500)
• Immatics Biotechnologies and Celgene
CEO of the Year
• Erik Van Den Berg, AM-Pharma
M&A Deal of the Year
• Boehringer Ingelheim and Amal Therapeutics
Clinical Trial of the Year
• Rexgenero, REX-001, Phase III, Ischemic Ulcer Immunotherapy
Biotech Company of the Year
• Astex Pharmaceuticals
• HOOKIPA Pharma
• Immatics Biotechnologies
Medtech Company of the Year:
The winners will be announced on the evening of 19th November at the Lifestars Awards dinner and networking event held at the Honourable Artillery Company in London, following the LSX Inv€$tival Showcase. The event precedes the Jefferies Annual Healthcare Conference.
The full list of award categories and finalists, as well as further information on the awards can be found here.
Commenting on the announcement, Sue Charles, Managing Partner of Instinctif Partners Life Sciences’ practice, and Lifestars Awards Judging Panel member, said:
“Awards provide an opportunity for successes seen in the life sciences industry to be showcased and celebrated. The Lifestars Awards are no exception and bring together industry leaders from across Europe to applaud the outstanding progress, innovation and achievements seen across the sector.
It has been a strong year for our clients, and we are delighted to see their achievements reflected in the impressive roster of finalists. We wish them all the best of luck for the night.”
About Instinctif Partners Life Sciences
Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences practice has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.
Sue CharlesManaging Partner